Safety/Tolerability and efficacy of rivastigmine in taiwanese patients with Alzheimer's disease: a prospective post-marketing surveillance study.
Saved in:
| Title: | Safety/Tolerability and efficacy of rivastigmine in taiwanese patients with Alzheimer's disease: a prospective post-marketing surveillance study. |
|---|---|
| Authors: | Chiu PY; Lin Shin Hospital, Taichung, Taiwan., Dai DE, Hsu HP, Lee C, Lin JJ, Kuo HC, Huang YC, Liu YC, Tsai CP |
| Source: | Clinical drug investigation [Clin Drug Investig] 2009; Vol. 29 (11), pp. 729-38. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print Cited Medium: Print ISSN: 1173-2563 (Print) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 19813776 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety/Tolerability and efficacy of rivastigmine in taiwanese patients with Alzheimer's disease: a prospective post-marketing surveillance study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chiu+PY%22">Chiu PY</searchLink>; Lin Shin Hospital, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Dai+DE%22">Dai DE</searchLink><br /><searchLink fieldCode="AU" term="%22Hsu+HP%22">Hsu HP</searchLink><br /><searchLink fieldCode="AU" term="%22Lee+C%22">Lee C</searchLink><br /><searchLink fieldCode="AU" term="%22Lin+JJ%22">Lin JJ</searchLink><br /><searchLink fieldCode="AU" term="%22Kuo+HC%22">Kuo HC</searchLink><br /><searchLink fieldCode="AU" term="%22Huang+YC%22">Huang YC</searchLink><br /><searchLink fieldCode="AU" term="%22Liu+YC%22">Liu YC</searchLink><br /><searchLink fieldCode="AU" term="%22Tsai+CP%22">Tsai CP</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229504817%22">Clinical drug investigation</searchLink> [Clin Drug Investig] 2009; Vol. 29 (11), pp. 729-38. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9504817 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>1173-2563 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211732563%22">11732563 </searchLink><i>NLM ISO Abbreviation: </i>Clin Drug Investig <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=19813776 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2165/11315320-000000000-00000 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 729 Titles: – TitleFull: Safety/Tolerability and efficacy of rivastigmine in taiwanese patients with Alzheimer's disease: a prospective post-marketing surveillance study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chiu PY – PersonEntity: Name: NameFull: Dai DE – PersonEntity: Name: NameFull: Hsu HP – PersonEntity: Name: NameFull: Lee C – PersonEntity: Name: NameFull: Lin JJ – PersonEntity: Name: NameFull: Kuo HC – PersonEntity: Name: NameFull: Huang YC – PersonEntity: Name: NameFull: Liu YC – PersonEntity: Name: NameFull: Tsai CP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2009 Type: published Y: 2009 Identifiers: – Type: issn-print Value: 1173-2563 Numbering: – Type: volume Value: 29 – Type: issue Value: 11 Titles: – TitleFull: Clinical drug investigation Type: main |
| ResultId | 1 |
